Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05457985 · ClinicalTrials.gov registry record · NA

Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

A NA study of PTSD, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
430
Enrollment target
13
Study locations

NCT05457985: Recruiting NA study of PTSD, sponsored by University of Michigan.

NCT05457985 is a NA study of PTSD that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 430 participants, above the 299-participant average among 154 other PTSD trials with a reported enrollment target (44% higher). The trial reports 13 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05457985, a NA study of PTSD, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
430 participants
Enrollment target
13
Study locations

Study Summary

This trial is being completed to develop a stepped-care talk therapy model for patients with PTSD. Specifically, this study is testing whether beginning with one type of therapy is better than beginning with another type of therapy, and whether moving to a different therapy after four sessions is more helpful than staying with the same therapy, depending on how well it is working. The central hypothesis is that beginning with a low- or medium-intensity PTSD intervention and then titrating intensity based on early indications of response will result in clinically significant PTSD symptom reduction with parsimony of resources.

Primary Outcome

The CAPS-5 is a clinician-rated PTSD rating scale consisting of 30 items; the total score is calculated as the sum of 20 items assessing the 20 DSM-5 PTSD symptoms. These symptom items are scored on a 5-point scale from 0 (absent) to 4 (extreme/incapacitating). The total score of the 20 items ranges from 0 to 80 with higher scores indicating more severe PTSD symptoms. Therefore, a decrease in the total score indicates symptom improvement.

Conditions Studied

Interventions

  • BEHAVIORAL Prolonged Exposure for Primary Care (PE-PC)
  • BEHAVIORAL Full Prolonged Exposure
  • BEHAVIORAL Clinician Supported PTSD Coach App

Study Locations (13)

Michigan

  • Family Health Care - Baldwin
  • Grace Health - Battle Creek
  • Genesee Community Health Center - Flint
  • Hamilton Community Health Network - Flint
  • Cherry Health - Grand Rapids
  • MidMichigan Community Health Services - Houghton Lake
  • Upper Great Lakes Family Health Care Center - Menominee
  • Family Medical Center of Michigan - Monroe
  • Sterling Area Health Center - Sterling

Missouri

  • Family Care Health Centers - St Louis

North Carolina

  • Western North Carolina Community Health Services - Asheville

Texas

  • CommUnityCare Health Centers - Austin

Washington

  • Unity Care NW - Bellingham

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2022-06-23
Est. Completion 2026-05
Phase NA
University of Michigan

1,327 total trials

What NCT05457985 shows while recruiting

NCT05457985 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, above the 299-participant average among 154 other PTSD trials with a reported enrollment target (44% higher).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 3 interventions - of which Prolonged Exposure for Primary Care (PE-PC) is the first listed.

NCT05457985 lists 13 locations in 5 states (Michigan, Missouri, North Carolina).

Frequently Asked Questions

What is clinical trial NCT05457985 about?

NCT05457985 is a clinical study titled "Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers". This trial is being completed to develop a stepped-care talk therapy model for patients with PTSD. Specifically, this study is testing whether beginning with one type of therapy is better than beginning with another type of therapy, and whether moving to a different therapy after four sessions is mo...

What is the current status of trial NCT05457985?

This trial is currently recruiting. It is a NA study. The enrollment target is 430 participants. The study started on 2022-06-23. Estimated completion is 2026-05.

What conditions does trial NCT05457985 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT05457985?

The interventions under investigation include: Prolonged Exposure for Primary Care (PE-PC) (BEHAVIORAL), Full Prolonged Exposure (BEHAVIORAL), Clinician Supported PTSD Coach App (BEHAVIORAL).

Who is sponsoring clinical trial NCT05457985?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05457985 being conducted?

This trial has 13 study locations across Michigan, Missouri, North Carolina, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05457985's enrollment target sits among peer trials

430 10th of 154 higher than 145 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05327023 · 430 participants · Phase 1

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  • NCT05532982 · 430 participants

    Parkinson's Disease in Asian Americans

  • NCT05844891 · 430 participants · NA

    Telehealth-Enhanced Asthma Care for Home After the Emergency Room

  • NCT05867251 · 430 participants · Phase 1

    Study of AVZO-021 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05457985, the US trial registry maintained by the National Library of Medicine. NCT05457985 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.